BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26251826)

  • 21. SPI1 activates TGF-β1/PI3K/Akt signaling through transcriptional upregulation of FKBP12 to support the mesenchymal phenotype of glioma stem cells.
    Song Y; Zhang Y; Wang X; Han X; Shi M; Xu L; Yu J; Zhang L; Han S
    Brain Pathol; 2024 May; 34(3):e13217. PubMed ID: 37865975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.
    Minata M; Audia A; Shi J; Lu S; Bernstock J; Pavlyukov MS; Das A; Kim SH; Shin YJ; Lee Y; Koo H; Snigdha K; Waghmare I; Guo X; Mohyeldin A; Gallego-Perez D; Wang J; Chen D; Cheng P; Mukheef F; Contreras M; Reyes JF; Vaillant B; Sulman EP; Cheng SY; Markert JM; Tannous BA; Lu X; Kango-Singh M; Lee LJ; Nam DH; Nakano I; Bhat KP
    Cell Rep; 2019 Feb; 26(7):1893-1905.e7. PubMed ID: 30759398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.
    Chen Z; Wang S; Li HL; Luo H; Wu X; Lu J; Wang HW; Chen Y; Chen D; Wu WT; Zhang S; He Q; Lu D; Liu N; You Y; Wu W; Wang H
    Mol Ther; 2022 Jul; 30(7):2568-2583. PubMed ID: 35351656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.
    Gu C; Banasavadi-Siddegowda YK; Joshi K; Nakamura Y; Kurt H; Gupta S; Nakano I
    Stem Cells; 2013 May; 31(5):870-81. PubMed ID: 23339114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
    Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J
    Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.
    Lu G; Chang JT; Liu Z; Chen Y; Li M; Zhu JJ
    Mol Neurobiol; 2016 Nov; 53(9):6511-6525. PubMed ID: 26614510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.
    Murata H; Yoshimoto K; Hatae R; Akagi Y; Mizoguchi M; Hata N; Kuga D; Nakamizo A; Amano T; Sayama T; Iihara K
    J Neurooncol; 2015 Oct; 125(1):33-41. PubMed ID: 26272600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
    Huang T; Wan X; Alvarez AA; James CD; Song X; Yang Y; Sastry N; Nakano I; Sulman EP; Hu B; Cheng SY
    Autophagy; 2019 Jun; 15(6):1100-1111. PubMed ID: 30654687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
    Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
    J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment.
    Vo VTA; Kim S; Hua TNM; Oh J; Jeong Y
    Commun Biol; 2022 Jun; 5(1):593. PubMed ID: 35710828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.
    Narayanan A; Gagliardi F; Gallotti AL; Mazzoleni S; Cominelli M; Fagnocchi L; Pala M; Piras IS; Zordan P; Moretta N; Tratta E; Brugnara G; Altabella L; Bozzuto G; Gorombei P; Molinari A; Padua RA; Bulfone A; Politi LS; Falini A; Castellano A; Mortini P; Zippo A; Poliani PL; Galli R
    Cell Death Differ; 2019 Sep; 26(9):1813-1831. PubMed ID: 30538287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERK Phosphorylation Regulates the Aml1/Runx1 Splice Variants and the TRP Channels Expression during the Differentiation of Glioma Stem Cell Lines.
    Santoni G; Nabissi M; Amantini C; Santoni M; Ricci-Vitiani L; Pallini R; Maggi F; Morelli MB
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity.
    Ricklefs F; Mineo M; Rooj AK; Nakano I; Charest A; Weissleder R; Breakefield XO; Chiocca EA; Godlewski J; Bronisz A
    Cancer Res; 2016 May; 76(10):2876-81. PubMed ID: 27013191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies.
    Visioli A; Trivieri N; Mencarelli G; Giani F; Copetti M; Palumbo O; Pracella R; Cariglia MG; Barile C; Mischitelli L; Soriano AA; Palumbo P; Legnani F; DiMeco F; Gorgoglione L; Pesole G; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2023 Sep; 42(1):244. PubMed ID: 37735434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma.
    Takashima Y; Kawaguchi A; Yamanaka R
    Cells; 2019 Oct; 8(11):. PubMed ID: 31653034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells.
    Stanzani E; Pedrosa L; Bourmeau G; Anezo O; Noguera-Castells A; Esteve-Codina A; Passoni L; Matteoli M; de la Iglesia N; Seano G; Martínez-Soler F; Tortosa A
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceramide Composition in Exosomes for Characterization of Glioblastoma Stem-Like Cell Phenotypes.
    Melero-Fernandez de Mera RM; Villaseñor A; Rojo D; Carrión-Navarro J; Gradillas A; Ayuso-Sacido A; Barbas C
    Front Oncol; 2021; 11():788100. PubMed ID: 35127492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
    Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
    Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.